Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Janssen Pharmaceutica is 1.0% (low). The company has been active since 1934 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
30 mandates
27
active directors
Robin GommersDirectorFrank LambrechtsDirectorBart PhilipsDirector+27 in history
All directors & mandates Publicationslatest 05-06-2026
200
publications in the State GazettePublication in the Belgian Official Gazette — Minor changeAll publications & acts Network & structure
2
connected companiesSee network & structure
Connections
2 connected companiesSubsidiary · 1 location
→
Subsidiary · 1 location
→
Trust signals
3 signalsLong-established
Founded in 1934 — 91 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone1.0%
Low
0%0,5%1,5%4%10%≥25%
Multiple establishment units
+Long track record
−Lower-risk legal form
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen24421Computerinfrastructuur, gegevensverwerking, hosting en aanverwante activiteiten63100Gegevensverwerking, webhosting en aanverwante activiteiten63110Overige technische testen en toetsen71209Overige technische testen en toetsen71209Gegevensverwerking72300Technische testen en analyses74302
Primary activity highlighted.
Names & trade names
| Legal nameNL | Janssen Pharmaceutica |
| Trade nameEN | Janssen Research & Development, Johnson & Johnson, J&J, Johnson & Johnson Innovative Medicine, J&J Innovative Medicine |
| Trade nameNL | Janssen Research & Development, Johnson & Johnson, J&J, Johnson & Johnson Innovative Medicine, J&J Innovative Medicine |
Registered office
Turnhoutseweg 30
2340 Beerse, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.